Michihiro Tsuchiya
Director/Board Member presso SUMITOMO ELECTRIC INDUSTRIES, LTD.
Profilo
Michihiro Tsuchiya è nel consiglio di amministrazione di Sumitomo Electric Industries Ltd. e RaQualia Pharma, Inc. In passato ha occupato la posizione di presidente della Mitsubishi Tanabe Pharma Corp. Ha ricevuto un dottorato dall'Università di Kyoto.
Posizioni attive di Michihiro Tsuchiya
| Società | Posizione | Inizio |
|---|---|---|
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Director/Board Member | 01/06/2018 |
| RAQUALIA PHARMA INC. | Director/Board Member | 26/03/2020 |
Precedenti posizioni note di Michihiro Tsuchiya
| Società | Posizione | Fine |
|---|---|---|
| MITSUBISHI CHEMICAL GROUP CORPORATION | Director/Board Member | - |
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Chief Executive Officer | 01/04/2014 |
Formazione di Michihiro Tsuchiya
| Kyoto University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Producer Manufacturing |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
| RAQUALIA PHARMA INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
The Kaiteki Institute, Inc.
The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Commercial Services |
- Borsa valori
- Insiders
- Michihiro Tsuchiya
